%0 Journal Article
%A Martínez-Cuadrón, David
%A Boluda, Blanca
%A Martínez, Pilar
%A Bergua, Juan
%A Rodríguez-Veiga, Rebeca
%A Esteve, Jordi
%A Vives, Susana
%A Serrano, Josefina
%A Vidriales, Belen
%A Salamero, Olga
%A Cordón, Lourdes
%A Sempere, Amparo
%A Jiménez-Ubieto, Ana
%A Prieto-Delgado, Julio
%A Díaz-Beyá, Marina
%A Garrido, Ana
%A Benavente, Celina
%A Pérez-Simón, José Antonio
%A Moscardó, Federico
%A Sanz, Miguel A
%A Montesinos, Pau
%A CETLAM and PETHEMA groups
%T Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
%D 2018
%U http://hdl.handle.net/10668/12172
%X The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.The original version of this article was revised: The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández.
%~